MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2021-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	119 Pages	Triton Market Research	July, 2021	TRTN16847484

Best Price Guarantee
Price	from $1,500
Length	119 Pages
Publisher	Triton Market Research
Published Date	July, 2021
SKU	TRTN16847484

MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2021-2028

MARKET OUTLOOK

Triton’s report alludes that the Middle East and Africa biosurgery market is predicted to showcase revenue growth at a CAGR of 7.19% through the period 2021-2028. South Africa, Turkey, the United Arab Emirates, Saudi Arabia, and Rest of Middle East & Africa outline the market in this region.

In the region, Turkey’s medical tourism industry is witnessing a significant growth, owing to the availability of affordable surgeries compared to other countries, such as the United States. This has resulted in the rise in the number of medical tourists entering the country seeking weight loss surgeries, which are cost-effective. For instance, the cost of gastric sleeve surgery is almost 70% less than the United Kingdom. Hence, the well-developed medical infrastructure increases the demand for biosurgery products for these treatments, simultaneously boosting the biosurgery market on a positive growth trajectory.

Furthermore, South Africa has observed a substantial surge in surgical procedures in recent years. As per the WHO, in the past, non-communicable diseases were evaluated to account for a significant amount of total death, out of which cardiovascular diseases accounted for approximately 19% of the deaths. Here, it is estimated that the growth in geriatric population will enhance the deaths relating to these diseases in the near future. Above all, there has been growth in the number of surgical procedures performed within the country, which increases the demand for biosurgery products to a large extent. Hence, such developments are likely to open new avenues for the biosurgery products over the forecast period.

COMPETITIVE OUTLOOK

The key enterprises profiled in the biosurgery market consist of B Braun Melsungen AG, RTI Surgical, Wright Medical Group NV, Zimmer Biomet Holdings Inc, Stryker Corporation, and Sanofi.

1. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – SUMMARY
2. INDUSTRY OUTLOOK: 2.1. IMPACT OF COVID-19 ON BIOSURGERY MARKET; 2.2. TRENDS IN BIOSURGERY TECHNOLOGY; 2.3. KEY INSIGHTS; 2.4. PORTER’S FIVE FORCES MODEL; 2.4.1. THREAT OF NEW ENTRANTS; 2.4.2. THREAT OF SUBSTITUTE PRODUCTS; 2.4.3. BARGAINING POWER OF BUYERS; 2.4.4. BARGAINING POWER OF SUPPLIERS; 2.4.5. COMPETITIVE RIVALRY; 2.5. MARKET ATTRACTIVENESS INDEX; 2.6. VENDOR SCORECARD; 2.7. KEY BUYING OUTLOOK; 2.8. KEY MARKET STRATEGIES; 2.8.1. CONTRACTS AND PARTNERSHIPS; 2.8.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES; 2.8.3. ACQUISITIONS & MERGERS; 2.8.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS; 2.9. MARKET DRIVERS; 2.9.1. GROWING AGING POPULATION; 2.9.2. SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS; 2.9.3. PREVALENCE OF SPINAL FUSION AND JOINT RECONSTRUCTION; 2.9.4. STRONG FOCUS ON RESEARCH AND DEVELOPMENT; 2.10. MARKET CHALLENGES; 2.10.1. HIGH COST OF SURGERIES; 2.10.2. COMPLICATIONS RELATED TO IMMUNE RESPONSE; 2.10.3. USAGE OF MINIMALLY INVASIVE SURGERIES; 2.11. MARKET OPPORTUNITIES; 2.11.1. RESEARCH AND INVESTMENTS IN BIOENGINEERING; 2.11.2. DEVELOPMENT OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – BY PRODUCT: 3.1. HEMOSTATIC AGENTS; 3.2. BONE-GRAFT SUBSTITUTES; 3.2.1. SYNTHETIC GRAFT EXTENDERS; 3.2.2. DEMINERALIZED BONE MATRIX; 3.2.3. BONE MORPHOGENETIC PROTEINS; 3.2.4. CELL-BASED MATRICES; 3.3. SURGICAL SEALING AGENTS; 3.3.1. NATURAL; 3.3.2. SYNTHETIC; 3.4. SOFT-TISSUE MANAGEMENT; 3.4.1. SYNTHETIC MESH/PATCH; 3.4.2. NATURAL MESH/PATCH; 3.5. ANTI-ADHESIVE AGENTS; 3.6. STAPLE LINE REINFORCEMENT
4. MIDDLE EAST AND AFRICA BIOSURGERY MARKET - BY APPLICATION: 4.1. ORTHOPEDIC SURGERY; 4.2. CARDIO AND THORACIC SURGERY; 4.3. NEURO AND SPINE SURGERY; 4.4. GENERAL SURGERY; 4.5. OTHER APPLICATIONS
5. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – BY SOURCE TYPE: 5.1. NATURAL; 5.2. SYNTHETIC
6. MIDDLE EAST AND AFRICA BIOSURGERY MARKET – COUNTRY OUTLOOK: 6.1. COUNTRY ANALYSIS; 6.1.1. SAUDI ARABIA; 6.1.2. UNITED ARAB EMIRATES; 6.1.3. TURKEY; 6.1.4. SOUTH AFRICA; 6.1.5. REST OF MIDDLE EAST & AFRICA
7. COMPETITIVE LANDSCAPE: 7.1. BAXTER INTERNATIONAL INC; 7.2. BECTON, DICKINSON AND COMPANY; 7.3. B BRAUN MELSUNGEN AG; 7.4. CSL LIMITED; 7.5. ETHICON INC (JOHNSON & JOHNSON); 7.6. INTEGRA LIFESCIENCES HOLDINGS CORPORATION; 7.7. MEDTRONIC PLC; 7.8. RTI SURGICAL; 7.9. SANOFI; 7.10. SMITH & NEPHEW PLC; 7.11. STRYKER CORPORATION; 7.12. WRIGHT MEDICAL GROUP NV; 7.13. ZIMMER BIOMET HOLDINGS INC
8. RESEARCH METHODOLOGY & SCOPE: 8.1. RESEARCH SCOPE & DELIVERABLES; 8.1.1. OBJECTIVES OF STUDY; 8.1.2. SCOPE OF STUDY; 8.2. SOURCES OF DATA; 8.2.1. PRIMARY DATA SOURCES; 8.2.2. SECONDARY DATA SOURCES; 8.3. RESEARCH METHODOLOGY; 8.3.1. EVALUATION OF PROPOSED MARKET; 8.3.2. IDENTIFICATION OF DATA SOURCES; 8.3.3. ASSESSMENT OF MARKET DETERMINANTS; 8.3.4. DATA COLLECTION; 8.3.5. DATA VALIDATION & ANALYSIS; LIST OF TABLES; TABLE 1: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION); TABLE 2: VENDOR SCORECARD; TABLE 3: CONTRACTS AND PARTNERSHIPS; TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES; TABLE 5: ACQUISITIONS & MERGERS; TABLE 6: NEW PRODUCT LAUNCHES & DEVELOPMENTS; TABLE 7: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION); TABLE 8: MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 9: MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 10: MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION); TABLE 11: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION); TABLE 12: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION); TABLE 13: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION); LIST OF FIGURES; FIGURE 1: MIDDLE EAST AND AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 2: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %); FIGURE 3: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION); FIGURE 4: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION); FIGURE 5: MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $ MILLION); FIGURE 6: MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $ MILLION); FIGURE 7: MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $ MILLION); FIGURE 8: MIDDLE EAST AND AFRICA BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION); FIGURE 9: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION); FIGURE 10: MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION); FIGURE 11: MIDDLE EAST AND AFRICA SURGICAL SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION); FIGURE 12: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION); FIGURE 13: MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $ MILLION); FIGURE 14: MIDDLE EAST AND AFRICA SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION); FIGURE 15: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION); FIGURE 16: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION); FIGURE 17: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY APPLICATION, 2020 & 2028 (IN %); FIGURE 18: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION); FIGURE 19: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION); FIGURE 20: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION); FIGURE 21: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION); FIGURE 22: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION); FIGURE 23: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SOURCE TYPE, 2020 & 2028 (IN %); FIGURE 24: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY NATURAL, 2021-2028 (IN $ MILLION); FIGURE 25: MIDDLE EAST AND AFRICA BIOSURGERY MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION); FIGURE 26: SAUDI ARABIA BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 27: UNITED ARAB EMIRATES BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 28: TURKEY BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 29: SOUTH AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION); FIGURE 30: REST OF MIDDLE EAST & AFRICA BIOSURGERY MARKET 2021-2028 (IN $ MILLION)